Journal Report

Chinese Medical Journal

Download PDF
Journal Information
Journal Title
Chinese Medical Journal
Publisher
Lippincott Williams and Wilkins
ISSN
0366-6999
E-ISSN
2542-5641
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Aptamers in cancer research: Focus on leukemia
Siyu Lin, Tingting Liu
2026-11-4
Burden of esophageal cancer in China and Asia: A systematic analysis for the Global Burden of Disease Study 2023
Lanwei Guo, Jiani Yuan, Chenxin Zhu et al.
2026-11-4
PROTAC-induced protein degradation in lung cancer
Jirui Wen, Yuhao Zou, Tang Feng et al.
2026-11-3
Distinct prognostic role of ALK fusion in early and advanced-stage lung adenocarcinoma stratified by clinicopathologic and radiologic features
Zelin Ma, Yi Liu, Hongjin Lai et al.
2026-11-2
A novel animal model of Meniere’s disease established by postauricular injection of inflammatory soup
Rui Zhao, Shiming Yang, Hao Zhao et al.
2026-11-2
Neu_SPP1 neutrophils are associated with anti-PD-1 resistance in non-small cell lung cancer and implicate VEGF signaling
Zhuoqi Li, Yanchen Zhao, Feng Sun et al.
2026-11-2
Machine learning algorithms integrating radiomics and clinical features for mortality prediction in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation
Min Cheng, Chao Sun, Yuqian Sun et al.
2026-11-2
Association between light at night and diabetic retinopathy is modified by residential greenness: A nationwide study in China
Zilin Wang, Zhihan Zhang, Yunxuan Wei et al.
2026-10-30
Air pollution exposure and death from different subtypes of kidney diseases: A nationwide, individual-level, case-crossover study in China
Yalan Xiao, Fanna Liu, Ya Gao et al.
2026-10-30
Bimekizumab in Chinese patients with active radiographic axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE 2 study
Jieruo Gu, Liangjing Lu, Qiang Wang et al.
2026-10-29
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 5, 2026 02:33